Sol-Gel Technologies Ltd. - Ordinary Shares (SLGL)
7.2350
+0.0050 (0.07%)
NASDAQ · Last Trade: Jun 7th, 9:26 PM EDT
The company’s diluted loss per share came in at $3.2, exceeding an estimated loss of $1.2.
Via Stocktwits · May 23, 2025

Via Benzinga · December 24, 2024

SLGL stock results show that Sol-Gel Technologies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 16, 2024

SLGL stock results show that Sol-Gel Technologies missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 20, 2024

Via Benzinga · July 25, 2024

In the headline deal, Takeda acquires global rights from AC Immune of Switzerland for $100 million upfront and up to $2.1B in milestones.
Via Talk Markets · May 19, 2024

Sol-Gel Technologies (NASDAQ:SLGL) reported its Q1 earnings results on Friday, May 13, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via Benzinga · May 13, 2022

On Thursday, 369 companies hit new 52-week lows.
Via Benzinga · October 5, 2023

Friday's session saw 112 companies set new 52-week lows.
Via Benzinga · September 29, 2023

Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough.
Via InvestorPlace · March 15, 2023

Although penny stocks represent extremely high risks, a select few ideas could make for enticing long-term propositions.
Via InvestorPlace · February 23, 2023

On Tuesday, 386 stocks made new 52-week lows.
Via Benzinga · September 26, 2023

Friday's session saw 169 companies set new 52-week lows.
Via Benzinga · September 15, 2023

BTIG cut the price target on Gain Therapeutics, Inc. (NASDAQ: GANX) from $30 to $10. BTIG analyst Thomas Shrader maintained a Buy rating on the stock. Gain Therapeutics shares rose 1.3% to close at $3.21 on Friday.
Via Benzinga · November 14, 2022

The generic drug market has been growing since 1984 when the Hatch-Waxman Act encouraged manufacturing generics and developed a framework to regulate them.
Via Benzinga · November 7, 2022

Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday.
Via Benzinga · March 22, 2023

U.S. stocks traded mostly higher midway through trading, with the Dow Jones surging more than 300 points on Monday.
Via Benzinga · October 24, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.
Via Benzinga · June 29, 2022

Upgrades
Via Benzinga · October 21, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
Via Benzinga · July 18, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
Via Benzinga · July 15, 2022